MAP1A (Microtubule Associated Protein 1A) is a neuron-specific cytoskeletal protein that plays essential roles in microtubule stabilization, neuronal morphology, synaptic function, and intracellular transport. As part of the MAP1 family, MAP1A is critical for maintaining proper neuronal architecture and function. Dysregulation of MAP1A has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease.
| Property | Value |
|---|---|
| Protein Name | Microtubule Associated Protein 1A |
| Gene Symbol | MAP1A |
| UniProt ID | P78527 |
| PDB Structure | Not determined (large protein) |
| Molecular Weight | ~300 kDa |
| Protein Length | 2,678 amino acids |
| Subcellular Location | Axons, Dendrites, Microtubules, Synapses |
| Protein Family | MAP1 Family |
MAP1A is one of the largest neuronal proteins and is expressed exclusively in neurons. It is developmentally regulated, with highest expression during synaptogenesis and in mature neurons.
MAP1A has a distinctive multi-domain structure:
MAP1A binds to and stabilizes microtubules:
MAP1A is essential for proper neuronal shape:
MAP1A participates in synaptic processes:
MAP1A is significantly implicated in Alzheimer's disease pathogenesis:
Research has shown decreased MAP1A expression in AD hippocampus and cortex, correlating with disease severity.
MAP1A plays several roles in PD:
| Brain Region | Expression Level |
|---|---|
| Hippocampus | High |
| Cerebral Cortex | High |
| Cerebellum | High |
| Substantia Nigra | Moderate |
| Spinal Cord | Moderate |
| Peripheral nerves | Low |
MAP1A expression is neuron-specific and developmentally regulated, with peak expression during synaptogenesis.
| Approach | Description | Status |
|---|---|---|
| Microtubule stabilization | Small molecule stabilizers | Research |
| Gene therapy | MAP1A expression | Preclinical |
| Kinase inhibitors | Reduce pathological phosphorylation | Research |
| Neurotrophic factors | Enhance MAP1A expression | Research |
The study of Microtubule Associated Protein 1A Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Tucker RP. The roles of microtubule-associated proteins in brain morphogenesis. Prog Neurobiol. 1990;35(5):351-361. PMID:2134109.
[2] Gonzalez-Billault C, et al. MAP1A expression in brain development and neurodegeneration. J Neurosci Res. 2002;70(5):656-666. PMID:12424577.
[3] Harada A, et al. Microtubule-associated protein 1A in neuronal function. Neurosci Res. 2002;44(1):1-12. PMID:12216570.
[4] Veeranna, et al. Phosphorylation of MAP1A in Alzheimer's disease. J Neurochem. 2008;105(3):917-927. PMID:18182064.
[5] Chen J, et al. MAP1A and neurodegeneration. Cell Mol Neurobiol. 2020;40(8):1247-1260. PMID:32107745.
[6] Yu Y, et al. Axonal transport deficits in neurodegenerative diseases. J Neurochem. 2021;158(2):222-238. PMID:33503218.